首页>
外国专利>
RECOMBINANT PLASMID DNA pHIG05, CODING HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine, CELL Escherichia coli, TRANSFORMED BY RECOMBINANT PLASMID DNA PHIG05, AND STRAIN OF BACTERIA Escherichia coli JM109/pHIG05-PRODUCENT OF HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine
RECOMBINANT PLASMID DNA pHIG05, CODING HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine, CELL Escherichia coli, TRANSFORMED BY RECOMBINANT PLASMID DNA PHIG05, AND STRAIN OF BACTERIA Escherichia coli JM109/pHIG05-PRODUCENT OF HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine
FIELD: biotechnologies.;SUBSTANCE: invention represents a recombinant plasmid DNA pHIG05, guiding synthesis of hybrid human protein with human proinsulin Glargine, containing DNA that codes hybrid protein with human proinsulin Glargine with size of 134 a.o. with amino acid sequence shown in fig.2, containing amino acid sequences of a leader peptide, in the form of an N-end fragment of human gamma-interferon connected to human proinsulin Glargine by peptide linker. On the basis of the recombinant plasmid pHIG05 a strain Escherichia coli JM109/pHIG05 is produced - producer of hybrid protein with proinsulin Glargine, registered in the Federal State Unitary Enterprise GosNIIgenetikie VKPM under No.V-11408.;EFFECT: usage of proposed inventions makes it possible to simplify technology of Glargine insulin extraction and to increase its yield.;4 cl, 2 dwg, 2 ex
展开▼
机译:发明领域本发明涉及重组质粒DNA pHIG05,其指导人人胰岛素原甘精胰岛素杂合人蛋白的合成,该DNA包含编码人胰岛素原甘草精杂合蛋白的DNA,大小为134a.o。具有图2所示的氨基酸序列的氨基酸序列,其包含前导肽的氨基酸序列,其形式为人γ-干扰素的N-末端片段,其通过肽接头与人胰岛素原甘精胰岛素相连。在重组质粒pHIG05的基础上,生产了大肠杆菌JM109 / pHIG05菌株-含有胰岛素原甘精胰岛素的杂交蛋白生产商,已在联邦国营单一企业GosNIIgenetikie VKPM中注册,注册号为V-11408。可以简化甘精胰岛素提取技术并提高其收率。; 4 cl,2 dwg,2 ex
展开▼